Mayne Pharma CEO Steps Down Amid $475m Metrics Contract Services Sale

CEO’s Departure Marks Turning Point For Mayne Pharma

 
• By Rosalind Rei
  
GB_Boardroom_08_22
Richards had been with Mayne since 2012 • Source: Shutterstock

More from Leadership

More from Generics Bulletin